Previous Close | 120.48 |
Open | 121.16 |
Bid | 121.20 x N/A |
Ask | 121.56 x N/A |
Day's Range | 121.16 - 121.16 |
52 Week Range | 71.47 - 131.78 |
Volume | |
Avg. Volume | 251 |
Market Cap | 48.245B |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | 85.93 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.